Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys Serving the City of Live Oak
If you are a resident of the City of Live Oak who has undergone breast reconstruction following a mastectomy, a breast lift (mastopexy), or a cosmetic augmentation, you may have been implanted with surgical materials that the FDA has never determined to be safe or effective for those specific uses. At The Manginello Law Firm, PLLC, known to our clients throughout Bexar County as Attorney911, we represent women and families in the City of Live Oak who are now facing the devastating consequences of defective breast mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds.
Whether you received your care at Northeast Methodist Hospital right here in the City of Live Oak area or traveled to the South Texas Medical Center for specialized oncology services, your health was dependent on the safety of the medical devices placed in your body. When manufacturers like Becton Dickinson, Allergan, and Davol prioritize market share over clinical evidence, the women of the City of Live Oak are the ones who pay the price in revision surgeries, chronic infections, and life-altering cancer diagnoses like BIA-ALCL. Our managing partner, Ralph Manginello, has spent twenty-seven years fighting for the catastrophically injured, and our associate attorney, Lupe Peña, brings a dedicated bilingual perspective to every City of Live Oak family we serve.
If you suspect your reconstruction is failing or you have received a diagnosis of breast implant-associated cancer, your first step is medical care, but your next step is understanding your legal rights. Call us at 1-888-ATTY-911 for a confidential, no-obligation consultation. We handle cases for the City of Live Oak community on a contingency-fee basis, meaning we only recover when you do.
Understanding the Devices Impacting City of Live Oak Patients
The medical device landscape for breast surgery has changed rapidly over the last decade. Many women in the City of Live Oak were told they were receiving “internal bras” or “biologic support” without being informed that these products were being used off-label. At Attorney911, we feel it is critical for City of Live Oak residents to understand exactly what was placed in their bodies.
Acellular Dermal Matrix (ADM)
Acellular Dermal Matrix (ADM) is a biologic graft, usually derived from human cadaver skin (allograft) or porcine/bovine tissue (xenograft). In the City of Live Oak surgical context, ADMs like AlloDerm, Strattice, and FlexHD are used to create a pocket for a breast implant or tissue expander. While these are biologic, they are not “live” tissue; they are processed to remove cells while leaving a collagen scaffold. We have seen significant cases in the City of Live Oak where these materials failed to integrate, leading to “red breast syndrome”—a non-infectious inflammatory reaction—or severe surgical site infections.
Bioabsorbable and Resorbable Scaffolds
Scaffolds like GalaFLEX or Phasix are synthetic materials designed to provide temporary support before being absorbed by the body. These are often marketed to City of Live Oak patients as a way to prevent the “bottoming out” of an implant. However, the science behind how these materials, particularly poly-4-hydroxybutyrate (P4HB), resorb in the human breast is fraught with concern. For many women in the City of Live Oak, these scaffolds fail to dissolve as advertised, remaining palpable, causing chronic pain, or triggering a foreign-body response long after they should have disappeared.
Synthetic Surgical Mesh
While less common in modern breast surgery, some synthetic meshes—similar to those used in hernia repairs—have been used off-label in the breast. These permanent polypropylene or composite materials carry a high risk of tissue erosion and chronic inflammation for the City of Live Oak recipient.
The FDA Regulatory Failure Affecting the City of Live Oak Community
One of the most shocking facts for City of Live Oak patients is that none of the surgical mesh or scaffold products currently used in breast surgery have been formally approved or cleared by the FDA for that purpose. This is a massive regulatory gap that we investigate in every City of Live Oak case we handle.
The manufacturers typically use the 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807, a company can bring a device to market by claiming it is “substantially equivalent” to a predicate device. This is not the same as the rigorous Premarket Approval (PMA) process required for Class III devices under 21 CFR Part 814. In the City of Live Oak market, we find that devices like GalaFLEX were cleared based on their similarity to surgical sutures, not based on clinical trials in breast tissue. As the FDA stated verbatim on November 9, 2023, in a letter to healthcare providers:
“The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
For a woman in the City of Live Oak, this means her surgeon may have been persuaded by manufacturer marketing to use a device that lacked a proven safety record in a sterile, oncological, or aesthetic breast environment. When we represent a client from the City of Live Oak, we focus on this lack of determined safety as a central theme in our litigation strategy.
Complications in City of Live Oak Breast Reconstruction Cases
The complications arising from these defective materials are not merely “side effects”—they are significant medical injuries that often require multiple revision surgeries. If you live in the City of Live Oak and recognize any of the following, you should contact us at 1-888-ATTY-911 to discuss preserving your evidence.
BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma
This is a CD30-positive, ALK-negative T-cell lymphoma that develops in the scar tissue around an implant. Since 2016, the World Health Organization has recognized this as a distinct malignancy. Many City of Live Oak women with textured implants, particularly the Allergan BIOCELL line, are at a statistically higher risk. BIA-ALCL often presents as a late-onset seroma (fluid collection) occurring 7 to 10 years after the original surgery.
BIA-SCC: Breast Implant-Associated Squamous Cell Carcinoma
This is an emerging and dangerous epithelial tumor identified by the FDA in September 2022. Unlike BIA-ALCL, which is a lymphoma of the immune system, BIA-SCC is a carcinoma of the skin-type cells in the capsule. It is aggressive and has been documented in City of Live Oak-area patients with both smooth and textured implants.
Red Breast Syndrome and Endotoxin Science
Red breast syndrome is a sterile, non-infectious redness that occurs specifically with ADM. Peer-reviewed research, including the Nguyen et al. (2019) framework, suggests this is caused by bacterial endotoxins—specifically lipopolysaccharides—that remain on the biologic graft even after sterilization. For a City of Live Oak patient, this inflammation mimics an infection but does not respond to antibiotics, often leading to the unnecessary loss of an implant.
Bioabsorbable Scaffold Malfunction
In the City of Live Oak, we are investigating cases where GalaFLEX or Phasix scaffolds caused late-stage complications. These include:
- Failure to Resorb: The device remains in the body years after its intended 18-to-24-month resorption window.
- Chronic Pain and Neuralgia: The stiffening of the scaffold can trap nerves, causing intercostal neuralgia.
- Tissue Erosion: The scaffold’s edges can become palpable or even extrude through the skin.
Why City of Live Oak Families Trust The Manginello Law Firm
When you are facing a corporate giant like Becton Dickinson (BD) or Allergan, you cannot rely on a generalist law firm. Defective device litigation requires an attorney who understands 21 CFR Part 803 Medical Device Reporting (MDR) and the complex preemption doctrines established in Riegel v. Medtronic and Medtronic v. Lohr.
Ralph Manginello brings twenty-seven years of continuous practice to your City of Live Oak case. Licensed by the State Bar of Texas (Bar Card No. 24007597) since November 1998, Ralph is admitted to the U.S. District Court for the Southern District of Texas and has been recognized as “Excellent” by Avvo with an 8.2 rating. Our firm’s current lead counsel status in high-profile institutional liability litigation, such as Bermudez v. Pi Kappa Phi, demonstrates our ability to prosecute multi-defendant cases seeking millions in damages.
Furthermore, we recognize that the City of Live Oak is a diverse community. Lupe Peña, our associate attorney and Saint Mary’s University graduate, conducts full client consultations in fluent Spanish. In the City of Live Oak, many patients find that their informed consent was compromised by language barriers. Lupe ensures that your voice is heard directly, without the need for filters or interpreters. Hablamos español, and we are ready to serve the City of Live Oak’s Spanish-speaking survivors.
Ralph Manginello and Lupe Peña provide the aggressive, multi-jurisdictional capability required to fight for the compensation you deserve. We have recovered over $50 million for our clients, and we bring that same tenacity to every City of Live Oak breast mesh injury claim.
The BD/Bard Whistleblower: What City of Live Oak Patients Should Know
Internal corporate documents and whistleblower testimony play a massive role in our City of Live Oak litigation. We closely monitor the record of Dr. Hooman Noorchashm, the former Medical Director at Becton Dickinson who was terminated in 2022 after raising safety alarms about GalaFLEX.
Dr. Noorchashm’s allegations are central to any City of Live Oak case involving BD products:
- Concealment of Cancer Recurrence: He alleged that breast cancer recurrences in BD’s own clinical trials were withheld from the FDA.
- Underreporting of Harm: He claimed that MAUDE (Manufacturer and User Facility Device Experience) reports were intentionally scrubbed of critical details.
- Off-Label Marketing: He challenged the company’s aggressive promotion of GalaFLEX to surgeons in cities like Live Oak for uses that lacked any determined safety profile.
If you received GalaFLEX or Phasix at a City of Live Oak facility, these whistleblower facts may be the key to overcoming the “learned intermediary” defense and showing that the manufacturer misled your surgeon just as they misled you.
Legal Posture: Statutes and Venues for City of Live Oak Residents
Navigating the legal framework in Texas and the City of Live Oak specifically requires timing and precision. Under Texas law, the statute of limitations for a product liability injury is generally two years from the date of the injury or the date the injury was discovered.
In the City of Live Oak, identifying that “discovery” date is complex. Many women do not realize their mesh was defective until they read about the FDA’s November 2023 letter or undergo a revision surgery where the surgeon finds intact scaffold material that should have resorbed. We utilize our deep understanding of the “discovery rule” to protect City of Live Oak clients whose original surgeries may have been years ago.
For City of Live Oak residents, the federal venue is typically the Western District of Texas, San Antonio Division. We analyze the specific docket profile of this district to ensure your case moves along a realistic path. If your case is part of a consolidated proceeding, like the Allergan BIOCELL MDL 2921 (currently set for a bellwether trial in October 2026), we ensure your City of Live Oak claim is filed in compliance with every Lone Pine order and procedural deadline.
Frequently Asked Questions for City of Live Oak Survivors
1. Is surgical mesh actually approved for breast surgery?
No. As we emphasize to every City of Live Oak client, the FDA has explicitly stated that no surgical mesh products are cleared or approved for use in breast reconstruction or augmentation. They are used “off-label” by surgeons, often based on manufacturer marketing that has not been clinically validated.
2. How do I know if mesh or ADM was used in my City of Live Oak surgery?
You must request your complete operative report and “implant log” from the hospital or surgical center. In the City of Live Oak, patients often receive a “device card,” but the operative report contains the essential brand, lot number, and Unique Device Identifier (UDI) that we need to identify the manufacturer.
3. What if my surgery in the City of Live Oak was ten years ago?
BIA-ALCL can have a latency period of a decade or more. Under the discovery rule in Texas, the clock may not start until you have a reason to know that your symptoms—like a late seroma or a new mass—are connected to a defective device. Do not assume you are out of time without a consultation from a wrongful death or personal injury attorney.
4. Can I sue for financial toxicity associated with my City of Live Oak medical bills?
Yes. Reconstruction complications are associated with thousands of dollars in excess costs. We seek “economic damages” to cover your past and future medical expenses, lost wages, and out-of-pocket costs, in addition to “non-economic damages” for your pain, suffering, and permanent disfigurement.
5. Does Attorney911 handle BIA-ALCL cases in the City of Live Oak?
Absolutely. We represent women facing lymphoma and carcinoma diagnoses linked to their implants. We understand the specific pathology (CD30+/ALK-) and the required staging/treatment protocols that form the basis of these catastrophic injury claims.
Evidence Preservation for Your City of Live Oak Case
If you are scheduled for an explantation or revision surgery at a center serving the City of Live Oak, you must act now to preserve the evidence. The physical mesh, ADM, or scaffold removed from your body is your property. We provide City of Live Oak clients with a “Chain of Custody” protocol to ensure:
- The device is not destroyed by the pathology lab.
- The device is preserved in a dry state or the specific medium required for future testing.
- All pathology slides are secured for independent review.
Without the physical evidence, the manufacturer may argue that your City of Live Oak surgeon made a technique error rather than the product being defective. Ralph Manginello and our team can coordinate this preservation on your behalf.
Contact Attorney911 for a Free City of Live Oak Consultation
At The Manginello Law Firm, PLLC, we believe that no woman in the City of Live Oak should have to bear the burden of a manufacturer’s negligence alone. Your body is not a laboratory for untested medical devices. Whether you are dealing with the loss of a reconstruction, a cancer diagnosis, or the fear of a recalled device, we are here to provide the expertise, authoritativeness, and trustworthiness you need.
Our Houston office serves as our principal hub, but we are deeply rooted in the City of Live Oak and Bexar County. With our 4.9-star rating across hundreds of reviews on Birdeye and our BBB-accredited status, you can trust that we treat every City of Live Oak client with the respect and urgency their case deserves.
Call us today at 1-888-ATTY-911 (1-888-288-9911). There is no cost to talk, no fee unless we win, and our consultations are entirely confidential.
Para nuestros clientes en City of Live Oak: Lupe Peña está disponible para una consulta completa en español. No permita que la barrera del idioma le impida buscar justicia. Llámenos hoy al 1-888-ATTY-911.
You have fought through surgery and perhaps through cancer. Now, let us fight for your justice in the City of Live Oak.
Disclaimer: This content is for educational purposes and does not constitute legal advice. Past results, including the Bermudez case and others mentioned, do not guarantee future outcomes. No attorney-client relationship is formed until a written contract is signed.
